YU18397A - MATRIX METALLOPROTEASES INHIBITING COMPOUND, 2(ω-ARYOYL-ALKYL)-4-BIARYL-4-OXOBUTYRIC ACID - Google Patents

MATRIX METALLOPROTEASES INHIBITING COMPOUND, 2(ω-ARYOYL-ALKYL)-4-BIARYL-4-OXOBUTYRIC ACID

Info

Publication number
YU18397A
YU18397A YU18397A YU18397A YU18397A YU 18397 A YU18397 A YU 18397A YU 18397 A YU18397 A YU 18397A YU 18397 A YU18397 A YU 18397A YU 18397 A YU18397 A YU 18397A
Authority
YU
Yugoslavia
Prior art keywords
disease
present
conditions
inhibiting
compounds
Prior art date
Application number
YU18397A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
William J. Scott
Margaret A. Popp
David S. Hartsough
Original Assignee
Bayer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corporation filed Critical Bayer Corporation
Publication of YU18397A publication Critical patent/YU18397A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU18397A 1996-05-15 1997-05-12 MATRIX METALLOPROTEASES INHIBITING COMPOUND, 2(ω-ARYOYL-ALKYL)-4-BIARYL-4-OXOBUTYRIC ACID YU18397A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64502996A 1996-05-15 1996-05-15

Publications (1)

Publication Number Publication Date
YU18397A true YU18397A (en) 1999-11-22

Family

ID=24587374

Family Applications (1)

Application Number Title Priority Date Filing Date
YU18397A YU18397A (en) 1996-05-15 1997-05-12 MATRIX METALLOPROTEASES INHIBITING COMPOUND, 2(ω-ARYOYL-ALKYL)-4-BIARYL-4-OXOBUTYRIC ACID

Country Status (22)

Country Link
EP (1) EP0904260B1 (sr)
JP (1) JP3524556B2 (sr)
CN (1) CN1119313C (sr)
AR (1) AR007099A1 (sr)
AT (1) ATE224350T1 (sr)
AU (1) AU715877B2 (sr)
BR (1) BR9709078A (sr)
CA (1) CA2254750C (sr)
CO (1) CO5011071A1 (sr)
DE (1) DE69715619T2 (sr)
ES (1) ES2184092T3 (sr)
HN (1) HN1997000070A (sr)
HR (1) HRP970242A2 (sr)
ID (1) ID17938A (sr)
PA (1) PA8429601A1 (sr)
PE (1) PE66198A1 (sr)
SV (1) SV1997000038A (sr)
TN (1) TNSN97081A1 (sr)
TW (1) TW457231B (sr)
WO (1) WO1997043240A1 (sr)
YU (1) YU18397A (sr)
ZA (1) ZA974028B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TNSN97083A1 (fr) 1996-05-15 2005-03-15 Bayer Corp Inhibition des matrices metalloproteases par la substitution d'acide biaryl oxobutyrique
TNSN97085A1 (fr) 1996-05-15 2005-03-15 Bayer Corp Substitution oxybuterique des acides comme inhibiteurs de la matrice metalloprotease
HRP970243B1 (en) 1996-05-15 2002-06-30 Bayer Ag Inhibition of matrix metalloproteases by substituted phenethyl compounds
ZA974033B (en) 1996-05-15 1998-02-19 Bayer Ag Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors.
US6288063B1 (en) 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
EP1031349A1 (en) * 1999-02-25 2000-08-30 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
US20170119776A1 (en) 2014-04-03 2017-05-04 Bayer Pharma Aktiengesellschaft Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
US20170114049A1 (en) 2014-04-03 2017-04-27 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases
EP3126339A1 (de) 2014-04-03 2017-02-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung
CN116687925B (zh) * 2022-11-04 2024-10-22 中国科学院遗传与发育生物学研究所 一种侵蚀性蛋白酶抑制剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS243570B1 (en) * 1984-08-31 1986-06-12 Miroslav Kuchar Omega-aryloxoalkane acids
GB9101468D0 (en) * 1991-01-23 1991-03-06 Ciba Geigy Coating compositions
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
ZA974028B (en) 1998-02-19
CO5011071A1 (es) 2001-02-28
HN1997000070A (es) 1997-09-08
CA2254750C (en) 2003-09-30
EP0904260B1 (en) 2002-09-18
TW457231B (en) 2001-10-01
CN1119313C (zh) 2003-08-27
JP2001509783A (ja) 2001-07-24
BR9709078A (pt) 1999-08-03
ES2184092T3 (es) 2003-04-01
EP0904260A1 (en) 1999-03-31
AU715877B2 (en) 2000-02-10
DE69715619D1 (de) 2002-10-24
PE66198A1 (es) 1998-10-23
PA8429601A1 (es) 2000-05-24
TNSN97081A1 (fr) 2005-03-15
AU3010497A (en) 1997-12-05
HRP970242A2 (en) 1998-04-30
ID17938A (id) 1998-02-12
CN1234791A (zh) 1999-11-10
AR007099A1 (es) 1999-10-13
WO1997043240A1 (en) 1997-11-20
DE69715619T2 (de) 2003-01-16
CA2254750A1 (en) 1997-11-20
ATE224350T1 (de) 2002-10-15
SV1997000038A (es) 1998-09-01
JP3524556B2 (ja) 2004-05-10

Similar Documents

Publication Publication Date Title
YU18397A (en) MATRIX METALLOPROTEASES INHIBITING COMPOUND, 2(ω-ARYOYL-ALKYL)-4-BIARYL-4-OXOBUTYRIC ACID
AR001999A1 (es) Derivados de acido carboxilico y composiciones conteniendolos, utiles como inhibidores de metaloproteasa de matriz, y procesos para su preparacion.
NO984112D0 (no) Hydroksyaminsyrederivater for anvendelse ved behandling av sykdommer relatert til bindevevdegradering
FI971312A0 (fi) Uudet prostaglandiinisyntaasin estäjät
YU44398A (sh) Derivati supstituisanog benzensulfonamida kao prolekovi cox-2 inhibitora
YU18597A (sh) Inhibitori matričnih metaloproteinaza, supstituisane biaril oksibuterne kiseline
DE60010675D1 (de) Caspase inhibitoren und deren verwendung
DK0927161T3 (da) Substitueret cyklisk amin-metalloproteaseinhibitorer
MEP60508A (en) Acylated arylcycloalkylamines and their use as pharmaceuticals
EA199900632A1 (ru) 2-амино-6-(2-замещенные-4-фенокси)-замещенные-пиридины
ATE232534T1 (de) Diazepinoindolone als phophodiesterase 4 inhibitoren
EA199900057A1 (ru) Ингибиторы матриксных металлопротеиназ
YU18497A (en) Matrix-metalloproteases inhibiting compounds, supstituted phenethyl compounds
YU18697A (en) Biaryl acetilenes as inhibitors of matrix metalloproteases
ID28365A (id) Turunan produk alami yang baru
BR0109348A (pt) Inibidores de metaloproteases n-substituìdos os quais contêm cadeias laterais carbocìclicas
DE69702182D1 (de) Alkylierte styrole als prodrugs zu cox-2-inhibitoren
DE69703791D1 (de) Diphenylstibene als prodrugs zu cox-2-inhibitoren
WO2001070693A3 (en) Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
DE59403966D1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
MEP33008A (en) Bicyclic imino acid derivatives used as inhibitors of matrixmetalloproteinases
ECSP972113A (es) Inhibicion de las metaloproteasas de matriz por acidos biariloxobutiricos sustituidos
TNSN97085A1 (fr) Substitution oxybuterique des acides comme inhibiteurs de la matrice metalloprotease
ECSP972112A (es) Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido